Sweden-based Nanexa has reported preclinical data for a long-acting semaglutide [...]

Nanexa has entered into a licence and option agreement with [...]

Nanexa says its long-acting subcutaneous technology could reduce the dosing [...]

Nanexa has received approval for a Japanese patent covering a [...]

The collaboration, Nanexa says, provides further proof that PharmaShell atomic [...]